Cited by 190NF-κB Signaling PathwaysInflammatory Bowel DiseaseCell death mechanisms and regulation

NEMO Prevents RIP Kinase 1-Mediated Epithelial Cell Death and Chronic Intestinal Inflammation by NF-κB-Dependent and -Independent Functions

Open access
Vlantis, Katerina, Wullaert, Andy, Polykratis, Apostolos, Kondylis, Vangelis, Dannappel, Marius, Schwarzer, Robin, Welz, Patrick, Corona, Teresa +5 more·2016·Immunity

Abstract

Intestinal epithelial cells (IECs) regulate gut immune homeostasis, and impaired epithelial responses are implicated in the pathogenesis of inflammatory bowel diseases (IBD). IEC-specific ablation of nuclear factor κB (NF-κB) essential modulator (NEMO) caused Paneth cell apoptosis and impaired antimicrobial factor expression in the ileum, as well as colonocyte apoptosis and microbiota-driven chronic inflammation in the colon. Combined RelA, c-Rel, and RelB deficiency in IECs caused Paneth cell apoptosis but not colitis, suggesting that NEMO prevents colon inflammation by NF-κB-independent functions. Inhibition of receptor-interacting protein kinase 1 (RIPK1) kinase activity or combined deficiency of Fas-associated via death domain protein (FADD) and RIPK3 prevented epithelial cell death, Paneth cell loss, and colitis development in mice with epithelial NEMO deficiency. Therefore, NEMO prevents intestinal inflammation by inhibiting RIPK1 kinase activity-mediated IEC death, suggesting that RIPK1 inhibitors could be effective in the treatment of colitis in patients with NEMO mutations and possibly in IBD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.immuni.2016.02.020

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • NEMO prevents RIPK1-driven intestinal inflammation and epithelial cell death, although underlying mechanisms remain poorly understood.

    “Inhibitor of nuclear factor kappa B kinase subunit gamma (IKBKG; best known as NEMO) also prevents RIPK1-driven intestinal inflammation and epithelial cell death, although the underlying molecular mechanisms remain poorly understood [511]”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Vlantis, K., Wullaert, A., Polykratis, A., Kondylis, V., Dannappel, M., Schwarzer, R., Welz, P., Corona, T., Walczak, H., Weih, F., Klein, U., Kelliher, M., & Pasparakis, M.
Affiliations
  • University of Cologne (DE)
  • University College London (GB)
  • Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) (DE)
  • Herbert Irving Comprehensive Cancer Center (US)
  • University of Massachusetts Chan Medical School (US)
Corresponding author
Pasparakis, Manolis
Venue
Immunity
Publisher
Elsevier BV
Published
2016-03
Volume
44
Issue
3
Pages
553-567
ISSN
1074-7613 (ISSN-L)
OpenAlex
W2299243013
Cited by
189
References
38
Citations by year
2026: 8 · 2025: 11 · 2024: 22 · 2023: 19 · 2022: 16 · 2021: 20 · 2020: 24 · 2019: 20 · 2018: 25 · 2017: 19 · 2016: 4
FWCI
9.46
Type
journal article
Language
en
Open access
Locations
  • Immunity (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Informationszentrum Lebenswissenschaften (ZB MED) (submittedVersion, cc-by-nc-nd)
  • Ghent University Academic Bibliography (Ghent University) (submittedVersion, other-oa)
Funders
  • European Commission (223151, 223404)
  • Deutsche Forschungsgemeinschaft (SPP-1656, SFB 670)
  • Universität Ulm
  • National Institutes of Health
  • Genentech
  • National Institute of Allergy and Infectious Diseases (R01AI075118)
  • FP7 Ideas: European Research Council (323040)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Keywords
NEMO, RIPK1, NF-κB, intestinal epithelial cells, epithelial cell death, chronic intestinal inflammation, colitis, inflammatory bowel disease, FADD, RIPK3, microbiota, RelA, c-Rel, RelB, RIPK1 inhibitors
MeSH terms
Animals, Cells, Cultured, Humans, Intestinal Mucosa, Mice, Inbred C57BL, Inflammatory Bowel Diseases, NF-kappa B, Apoptosis, Mice, Knockout, Paneth Cells, Proto-Oncogene Proteins c-rel, Intracellular Signaling Peptides and Proteins, Mice, Transcription Factor RelB, Transcription Factor RelA, Fas-Associated Death Domain Protein, Receptor-Interacting Protein Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review